Scalp care innovation must be driven by specific science, not borrowed claims from facial skincare. Consultant Trichologist Brian Plunkett highlights that the scalp possesses unique characteristics, including denser hair follicles, higher sebaceous activity, and a distinct microbiome. Marketing often suggests treating the scalp like facial skin, a notion Plunkett debunks. He points out that nearly half of individuals experience sensitive scalp complaints, demonstrating the need for targeted formulations. The global haircare market, projected for $96.82bn in revenue by 2025, sees scalp care as a major growth area.
Plunkett cautions against brands importing facial skincare concepts – actives, serums, exfoliants – without robust, scalp-specific proof. The scalp's epidermis and dermis are thicker, its blood supply richer, and its barrier function adapted for hair growth, not just environmental protection. These physiological differences mean sebaceous gland activity and microbial ecology behave differently than on the face. Phrases like 'clinically proven' are used without transparent studies, contradicting regulatory guidance.
For salon and barbershop owners, this suggests an opportunity. Focusing on evidence-based scalp treatments tailored to these unique biological differences, rather than generic 'skinified' approaches, could build trust. Businesses must scrutinise product claims, demanding greater transparency and scientifically validated scalp-specific efficacy to truly benefit clients.
